Targeting CD144, a key endothelial biomarker associated with cardiovascular diseases, this approach can enhance early diagnosis and monitoring of cardiovascular conditions, ultimately improving patient outcomes and reducing healthcare costs. The gene discussed is CDH5; the disease is cardiovascular disorder.